Xeris Pharmaceuticals Inc (XERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,598 | 19,519 | 45,716 | 42,045 | 32,269 |
| Marketable Securities | 96,190 | 56,030 | 66,917 | 0 | N/A |
| Receivables | 6,875 | 4,693 | 2,869 | 1,199 | 101 |
| Inventories | 8,353 | 2,176 | N/A | N/A | N/A |
| TOTAL | $152,212 | $87,483 | $117,899 | $44,053 | $33,174 |
| Non-Current Assets | |||||
| PPE Net | 6,707 | 7,853 | 2,034 | 788 | 312 |
| Investments And Advances | 0 | 13,231 | 0 | 0 | 0 |
| Other Non-Current Assets | 232 | 420 | 95 | 157 | 47 |
| TOTAL | $6,939 | $21,504 | $2,129 | $945 | $359 |
| Total Assets | $159,151 | $108,987 | $120,028 | $44,998 | $33,533 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,117 | 5,603 | 866 | 1,976 | 1,315 |
| Accrued Expenses | 8,873 | 3,332 | N/A | 2,557 | 902 |
| Other current liabilities | 322 | 284 | 1,092 | 93 | 47 |
| TOTAL | $28,207 | $27,338 | $10,172 | $4,860 | $2,527 |
| Non-Current Liabilities | |||||
| Long Term Debt | 87,021 | 58,305 | 31,890 | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | 234 | 263 |
| Other Non-Current Liabilities | 3,533 | 1,832 | 2,560 | 90 | 0 |
| TOTAL | $97,183 | $67,213 | $34,450 | $90 | $42 |
| Total Liabilities | $125,390 | $94,551 | $44,622 | $4,950 | $2,569 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,765 | 37,570 | 26,810 | N/A | N/A |
| Common Shares | 6 | 3 | 2 | 1 | 1 |
| Retained earnings | -337,385 | -246,245 | -120,665 | -60,585 | -34,031 |
| Other shareholders' equity | 6 | 43 | -52 | 97,878 | 62,898 |
| TOTAL | $33,761 | $14,436 | $75,406 | $40,048 | $30,964 |
| Total Liabilities And Equity | $159,151 | $108,987 | $120,028 | $44,998 | $33,533 |